bullous pemphigoid

Summary

Summary: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.

Top Publications

  1. ncbi Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease
    Rieko Izumi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
    J Am Acad Dermatol 56:S94-7. 2007
  2. ncbi Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease
    Cassian Sitaru
    Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany
    J Invest Dermatol 129:822-4. 2009
  3. ncbi Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris
    M J Rico
    Dermatology Service, New York VA Medical Center and Department of Dermatology, New York University, 423 East 23rd Street, New York, NY 10010, USA
    Br J Dermatol 140:1079-86. 1999
  4. ncbi Bullous pemphigoid and related subepidermal autoimmune blistering diseases
    Edit B Olasz
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Curr Dir Autoimmun 10:141-66. 2008
  5. ncbi Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
    Zhi Liu
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Autoimmun 31:331-8. 2008
  6. ncbi Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid
    Jozo Budimir
    School of Dental Medicine, University of Zagreb, Croatia
    Acta Clin Croat 47:13-8. 2008
  7. ncbi Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide
    Y Hirako
    Unit of Biosystems, Graduate School of Human Informatics, Nagoya University, Nagoya 464 01
    J Biol Chem 273:9711-7. 1998
  8. ncbi Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII
    Elena P Zimina
    J Invest Dermatol 128:2736-9. 2008
  9. ncbi Minocycline as a therapeutic option in bullous pemphigoid
    W J Loo
    Department of Dermatology, The Churchill, Oxford Radcliffe Hospital, Headington, Oxford, UK
    Clin Exp Dermatol 26:376-9. 2001
  10. ncbi A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice
    Janet A Fairley
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    J Invest Dermatol 127:2605-11. 2007

Research Grants

  1. Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
    Tanya N Mayadas; Fiscal Year: 2010
  2. PEMPHIGUS AND PEMPHIGOID
    Luis Diaz; Fiscal Year: 2005
  3. Mechanism of neurodegeneration in dystonia musculorum
    RONALD LIEM; Fiscal Year: 2007
  4. Complement Anaphylatoxin Receptors in Inflammation
    RICK WETSEL; Fiscal Year: 2005
  5. INTESTINAL TRANSCYTOSIS OF IGG IN ADULT LIFE
    Richard Blumberg; Fiscal Year: 2007
  6. INTESTINAL TRANSCYTOSIS OF IGG IN ADULT LIFE
    Richard S Blumberg; Fiscal Year: 2010
  7. INTESTINAL TRANSCYTOSIS OF IGG IN ADULT LIFE
    Richard Blumberg; Fiscal Year: 2009
  8. CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE
    David Norris; Fiscal Year: 1990
  9. EPITHELIALIZATION OF TISSUE ENGINEERED CORNEAS
    JEAN JACOB; Fiscal Year: 2003
  10. HEMIDESMOSOMES IN BULLOUS PEMPHIGOID
    GEORGE GIUDICE; Fiscal Year: 2007

Detail Information

Publications225 found, 100 shown here

  1. ncbi Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease
    Rieko Izumi
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
    J Am Acad Dermatol 56:S94-7. 2007
    We report the case of a 55-year-old female with bullous pemphigoid (BP) who was positive for anti-BP180 and anti-laminin 5 antibodies after development of graft-vs-host disease (GVHD) caused by a bone marrow transplant...
  2. ncbi Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease
    Cassian Sitaru
    Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany
    J Invest Dermatol 129:822-4. 2009
    b>Bullous pemphigoid (BP) is a prototypical organ-specific autoimmune disease. Autoantibodies unfold their blister-inducing potential by triggering an Fcgamma-dependent inflammatory reaction. The study by Iwata et al...
  3. ncbi Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris
    M J Rico
    Dermatology Service, New York VA Medical Center and Department of Dermatology, New York University, 423 East 23rd Street, New York, NY 10010, USA
    Br J Dermatol 140:1079-86. 1999
    ..cell marker expression in perilesional skin biopsies from patients with the autoimmune blistering diseases bullous pemphigoid (BP, n = 21) and pemphigus vulgaris (PV, n = 7)...
  4. ncbi Bullous pemphigoid and related subepidermal autoimmune blistering diseases
    Edit B Olasz
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Curr Dir Autoimmun 10:141-66. 2008
    The pemphigoid group of autoimmune blistering diseases includes distinct entities (bullous pemphigoid, mucous membrane pemphigoid, pemphigoid gestationis, linear IgA dermatosis and lichen planus pemphigoides) that are characterized by ..
  5. ncbi Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
    Zhi Liu
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Autoimmun 31:331-8. 2008
    b>Bullous pemphigoid (BP) is a cutaneous autoimmune inflammatory disease associated with subepidermal blistering and autoantibodies against BP180, a transmembrane collagen and major component of the hemidesmosome...
  6. ncbi Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid
    Jozo Budimir
    School of Dental Medicine, University of Zagreb, Croatia
    Acta Clin Croat 47:13-8. 2008
    ..onset of symptoms and therapy between patients with pemphigus vulgaris and those suffering from bullous pemphigoid. Based on clinical presentation, histopathologic analysis, direct and indirect immunofluorescence, Tzanck ..
  7. ncbi Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide
    Y Hirako
    Unit of Biosystems, Graduate School of Human Informatics, Nagoya University, Nagoya 464 01
    J Biol Chem 273:9711-7. 1998
    ..One of the putative cell-matrix adhesion molecules present in the HD is the 180-kDa bullous pemphigoid antigen (BP180), also termed type XVII collagen...
  8. ncbi Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII
    Elena P Zimina
    J Invest Dermatol 128:2736-9. 2008
  9. ncbi Minocycline as a therapeutic option in bullous pemphigoid
    W J Loo
    Department of Dermatology, The Churchill, Oxford Radcliffe Hospital, Headington, Oxford, UK
    Clin Exp Dermatol 26:376-9. 2001
    We present a retrospective analysis of patients with bullous pemphigoid (BP) treated with minocycline in the Department of Dermatology, Churchill Hospital, Oxford between July 1986 and May 2000...
  10. ncbi A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice
    Janet A Fairley
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    J Invest Dermatol 127:2605-11. 2007
    b>Bullous pemphigoid (BP) is an autoimmune disease characterized by subepidermal blistering. Based on previous work, IgG autoantibodies directed against BP180 are thought to be the primary pathogenic agent in BP...
  11. ncbi Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid
    Janet A Fairley
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    J Invest Dermatol 125:467-72. 2005
    b>Bullous pemphigoid (BP) is a subepidermal blistering disease characterized by autoantibodies against the hemidesmosomal protein BP180 (BPAg2, type XVII collagen)...
  12. ncbi Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid
    Mariko Yoshida
    Department of Dermatology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka 830-0011, Japan
    J Dermatol Sci 41:21-30. 2006
    BACKGROUND: By immunoblot analyses of normal human epidermal extracts, the 230kDa bullous pemphigoid antigen (BP230) is recognized by most bullous pemphigoid (BP) sera...
  13. ncbi Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration
    L Guo
    Howard Hughes Medical Institute, University of Chicago, Illinois 60637, USA
    Cell 81:233-43. 1995
    BPAG1 is the major antigenic determinant of autoimmune sera of bullous pemphigoid (BP) patients...
  14. ncbi Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid
    Giovanni Di Zenzo
    Istituto Dermopatico dell Immacolata, Molecular and Cell Biology Laboratory, IDI IRCCS, Rome, Italy
    Clin Immunol 128:415-26. 2008
    b>Bullous pemphigoid (BP) is an autoimmune bullous disease, associated with autoantibodies directed against the hemidesmosomal components BP180 and BP230...
  15. ncbi Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice
    Edit B Olasz
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    J Invest Dermatol 127:2807-17. 2007
    b>Bullous pemphigoid antigen 2 (BPAG2) is targeted by autoantibodies in patients with bullous pemphigoid (BP), and absent in patients with one type of epidermolysis bullosa (OMIM #226650)...
  16. ncbi Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies
    J R Stanley
    Dermatology Branch, National Cancer Institute, Bethesda, Maryland 20892
    J Clin Invest 82:1864-70. 1988
    Autoantibodies from bullous pemphigoid (BP) patients define a 230-kD protein found in the basement membrane of stratified squamous epithelia...
  17. ncbi Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid
    Wataru Nishie
    Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany
    J Immunol 185:4938-47. 2010
    ..Correspondingly, neoepitopes were found in the skin and blister fluids of patients with bullous pemphigoid, and bullous pemphigoid sera reacted with the peptide Leu(524)-Gly(532)...
  18. ncbi BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid
    Masakazu Kobayashi
    Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
    J Dermatol Sci 30:224-32. 2002
    b>Bullous pemphigoid (BP) is an acquired autoimmune subepidermal blistering disease against hemidesmosomal cytoplasmic BP230 and transmembrane BP180 proteins...
  19. ncbi A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid
    Kelly A N Messingham
    The Department of Dermatology, University of Iowa, Iowa City, IA, USA
    J Immunol Methods 346:18-25. 2009
    b>Bullous pemphigoid (BP) is a humoral autoimmune disease directed predominantly against the non-collagenous NC16A domain of the BP180 hemidesmosomal protein...
  20. ncbi The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1
    A Brown
    Institut du Cancer de Montreal, Centre de Recherche L C Simard, Quebec, Canada
    Nat Genet 10:301-6. 1995
    ..encodes an N-terminal actin binding domain and a C-terminal portion comprised of the hemidesmosomal protein, bullous pemphigoid antigen 1 (bpag1)...
  21. ncbi Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly
    Jan Koster
    The Netherlands Cancer Institute, Division of Cell Biology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Cell Sci 116:387-99. 2003
    ..The results show that: (1) bullous pemphigoid antigen (BP) 180 binds not only to BP230, but also to plectin...
  22. ncbi Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MACF (microtubule actin cross-linking factor)
    Masayo Okumura
    Unit of Biosystems, Graduate School of Human Informatics, Nagoya University, Nagoya 464 8601, Japan
    J Biol Chem 277:6682-7. 2002
    BPAG1 (bullous pemphigoid antigen 1) was originally identified as a 230-kDa hemidesmosomal protein and belongs to the plakin family, because it consists of a plakin domain, a coiled-coil rod domain and a COOH-terminal intermediate ..
  23. ncbi Autoantibodies to human alpha6 integrin in patients with oral pemphigoid
    K C Bhol
    Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, Boston, MA 02115, USA
    J Dent Res 80:1711-5. 2001
    ..Oral pemphigoid sera and anti-alpha6 antibody produced separation of epithelium from basement membrane (blister formation) of normal human buccal mucosa, after 48 hours, in organ culture...
  24. ncbi Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid
    S Verraes
    FRE 2260 CNRS, IFR 53 Biomolecules, University of Reims-Champagne Ardennes, Reims, France
    J Invest Dermatol 117:1091-6. 2001
    b>Bullous pemphigoid is a blistering disorder associated with autoantibodies directed against two components of hemidesmosomes, BP180 and BP230...
  25. ncbi Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts
    Monika Bowszyc-Dmochowska
    Dermatology, Medical University of Poznan, Poznan, Poland
    J Med 33:189-98. 2002
    The immediate hypersensitivity phenomena in bullous pemphigoid (BP) will be discussed in this review. There is prominent involvement of eosinophils in the pathogenesis of human BP...
  26. ncbi Role of intravenous immunoglobulin in the treatment of bullous pemphigoid: analysis of current data
    L Engineer
    Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, Boston, MA 02115, USA
    J Am Acad Dermatol 44:83-8. 2001
    BACKGROUND: Conventional therapy of severe bullous pemphigoid (BP) relies on the use of high-dose systemic corticosteroids with or without adjuvants, notably immunosuppressive agents...
  27. ncbi Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses
    E Laffitte
    Clinique de Dermatologie, , Rue Micheli du Crest 26, CH-1211 Geneva, Switzerland
    Br J Dermatol 144:760-8. 2001
    BACKGROUND: Autoantibodies to the extracellular domain (ECD) of bullous pemphigoid (BP) antigen 180 (BP180) are thought to play a crucial part in the pathophysiology of BP...
  28. ncbi Role of FcRs in animal model of autoimmune bullous pemphigoid
    Minglang Zhao
    Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill 27599, USA
    J Immunol 177:3398-405. 2006
    b>Bullous pemphigoid (BP) is a bullous dermatosis associated with autoantibodies directed against the hemidesmosomal Ags BP180 and BP230...
  29. ncbi Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid
    R Watanabe
    Department of Dermatology, Faculty of Medicine, University of Tokyo, 7 3 1 Hongo, Bunkyo, Tokyo 113 8655, Japan
    J Dermatol Sci 46:53-60. 2007
    ..Although the functions of APRIL have not been fully evaluated, recent studies suggest that circulating levels of APRIL are increased in various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis...
  30. ncbi Role of different pathways of the complement cascade in experimental bullous pemphigoid
    Kelly C Nelson
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    J Clin Invest 116:2892-900. 2006
    b>Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies directed against the hemidesmosomal proteins BP180 and BP230 and inflammation...
  31. ncbi A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
    Pascal Joly
    Department of Dermatology and Biostatistics, INSERM Unite 519, University of Rouen, Rouen, France
    N Engl J Med 346:321-7. 2002
    b>Bullous pemphigoid is the most common autoimmune blistering skin disease of the elderly...
  32. ncbi Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement fixation studies
    Khalid S Al-Karawi
    Department of Surgery, Dammam Central Hospital, Al Khobar 31952, Kingdom of Saudi Arabia
    Saudi Med J 23:1492-5. 2002
    ..immunoglobulin G (IgG) subclass distribution of tissue bound and circulating antibasement membrane zone antibodies in bullous pemphigoid. In addition, the complement fixing capability of circulating IgG subclasses was also investigated.
  33. ncbi Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid
    Iakov Shimanovich
    Department of Dermatology, , Ratzeburger Allee 160, , Germany
    J Pathol 204:519-27. 2004
    Epidermolysis bullosa acquisita (EBA) and bullous pemphigoid (BP) are two clinically and immunologically distinct autoimmune subepidermal blistering skin diseases associated with IgG autoantibodies against the dermal-epidermal junction...
  34. ncbi Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation
    Ruoyan Chen
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Immunol 169:3987-92. 2002
    b>Bullous pemphigoid (BP) is a subepidermal blistering disease associated with autoantibodies against two hemidesmosomal proteins, BP180 and BP230. Numerous inflammatory cells infiltrate the upper dermis in BP...
  35. ncbi Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease
    P Szabolcs
    Department of Pediatrics, Pediatric Stem Cell Transplant Program, Duke University Medical Center, Durham, NC 27710, USA
    Bone Marrow Transplant 30:327-9. 2002
    ..with two chimeric monoclonal antibodies (MoAb) targeting the autoimmune B cell clone responsible for bullous pemphigoid (BP) as a manifestation of steroid refractory chronic graft-versus-host disease (GVHD) that developed after ..
  36. ncbi Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid
    Shinji Kagami
    J Invest Dermatol 124:1088-90. 2005
  37. ncbi A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid
    Kerry E Buschman
    Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    J Cutan Pathol 29:282-6. 2002
    BACKGROUND: Bullous pemphigoid (BP) is an immune-mediated blistering disease, usually characterized immunopathologically by the linear deposition of IgG and C3 along the basement membrane zone (BMZ) of skin...
  38. ncbi Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy
    Ann Marie Powell
    Department of Dermatological Immunopathology, St John's Institute of Dermatology, St Thomas' Hospital, London, England
    Arch Dermatol 141:705-10. 2005
    ..CONCLUSIONS: The NC16a enzyme-linked immunosorbent assay is highly sensitive and highly specific in differentiating PG from PUPPP, and it is potentially a valuable tool in the serodiagnosis of PG...
  39. ncbi Guidelines for the management of bullous pemphigoid
    F Wojnarowska
    Department of Dermatology, Oxford Radcliffe Hospital, The Churchill, Old Road, Headington, Oxford OX3 7LJ, UK
    Br J Dermatol 147:214-21. 2002
    ..the Cochrane library, literature searches and the experience of the authors of managing patients with bullous pemphigoid in special and general clinics for over 10 years...
  40. ncbi Treatment considerations while awaiting the ideal bullous pemphigoid trial
    Diya F Mutasim
    Arch Dermatol 138:404. 2002
  41. ncbi A systematic review of treatments for bullous pemphigoid
    Nonhlanhla P Khumalo
    Department of Dermatology, Groote Schuur Hospital, Observatory, 7925 Capetown, South Africa
    Arch Dermatol 138:385-9. 2002
    To assess the effectiveness of treatments for bullous pemphigoid.
  42. ncbi Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid
    Katsushi Yamamoto
    Division of Oncology and Biology, Genome Research Group, National Institute of Radiological Sciences, Inage Ku, Chiba, Japan
    J Invest Dermatol 118:485-92. 2002
    b>Bullous pemphigoid is an inflammatory subepidermal blistering skin disease associated with an IgG autoimmune response to the type XVII collagen...
  43. ncbi Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid
    Zhi Liu
    Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA
    Blood 107:1063-9. 2006
    b>Bullous pemphigoid (BP) is an autoimmune disease associated with autoantibodies directed against the hemidesmosomal antigens anti-BP230 and anti-B180...
  44. ncbi Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies
    Heike Leyendeckers
    Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
    J Invest Dermatol 120:372-8. 2003
    b>Bullous pemphigoid is a subepidermal blistering disease characterized by the synthesis of autoantibodies against the 180 kDa and the 230 kDa bullous pemphigoid antigens...
  45. ncbi Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain
    M S Lin
    Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27759, USA
    J Invest Dermatol 115:955-61. 2000
    b>Bullous pemphigoid is a blistering skin disease characterized by autoantibodies directed against the NC16A domain of bullous pemphigoid 180 (collagen XVII), a transmembrane protein of epidermal basal cells...
  46. ncbi Demonstration of antibody to 230 kDa bullous pemphigoid antigen in lichen planus-like keratosis
    M Seishima
    Department of Dermatology, Ogaki Municipal Hospital, Minaminokawa cho 4 86, Ogaki City, 503 8502, Japan
    Eur J Dermatol 9:393-6. 1999
    We describe a 67-year-old man with lichen planus-like keratosis associated with anti-230 kDa bullous pemphigoid antigen (BPAG1) autoantibody...
  47. ncbi Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen
    L S Chan
    Veterans Affairs Chicago Health Care System, Department of Dermatology, Northwestern University Medical School, Ill 60611 3010, USA
    Arch Dermatol 135:569-73. 1999
    ..Bullous systemic lupus erythematosus is a generalized subepidermal blistering skin eruption in patients suffering from systemic lupus erythematosus. Type VII collagen was initially identified as the target antigen...
  48. ncbi Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid
    Z Liu
    Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226, USA
    J Immunol 155:5449-54. 1995
    b>Bullous pemphigoid (BP) and herpes gestationis (HG) are subepidermal blistering diseases associated with an autoimmune response directed against BP180, an epidermal hemidesmosomal glycoprotein...
  49. ncbi The pathophysiology of bullous pemphigoid
    Michael Kasperkiewicz
    Department of Dermatology, University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Clin Rev Allergy Immunol 33:67-77. 2007
    b>Bullous pemphigoid (BP) is a blistering skin disease characterized by an autoimmune response to 2 hemidesmosomal proteins within the dermal-epidermal junction, designated BP180 and BP230...
  50. ncbi Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid
    Antal Blazsek
    Department of Dermato Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary
    Exp Dermatol 17:446-54. 2008
    ..We aimed to study the presence of TTV in a group of patients with autoimmune bullous diseases with a further goal to identify long-lasting foreign antigen, such as TTV as possible triggers of skin-specific autoimmunity...
  51. ncbi Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis
    Maria A Barnadas
    Department of Dermatology, Hospital Sta Creu i St Pau, Barcelona, Spain
    Int J Dermatol 47:1245-9. 2008
    ..BP180-NC16a domain ELISA with that of an indirect immunofluorescence (IIF) testing in the evaluation of bullous pemphigoid (BP) and pemphigoid gestationis (PG), and analyzed the relationship between ELISA results and the presence ..
  52. ncbi Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid
    Z Liu
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Exp Med 188:475-82. 1998
    b>Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by deposition of autoantibodies at the basement membrane zone...
  53. ncbi Hemidesmosomes: roles in adhesion, signaling and human diseases
    L Borradori
    Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, NL 1066 CX, Amsterdam, The Netherlands
    Curr Opin Cell Biol 8:647-56. 1996
    ..These multiprotein complexes appear not only to mediate cell adhesion, but also to transduce signals from the extracellular matrix to the cell interior that may profoundly modulate cell behavior...
  54. ncbi Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid
    Yohei Iwata
    Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1 7 1 Sakamoto, Nagasaki, 852 8501, Japan
    Arch Dermatol 144:41-8. 2008
    To determine the prevalence, immunoglobulin subclass distribution, and clinical correlation of antibodies (Abs), especially of IgE Abs, to BP180 and BP230 in patients with bullous pemphigoid (BP).
  55. ncbi The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles
    C L Leung
    Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Cell Biol 154:691-7. 2001
    b>Bullous pemphigoid antigen 1 (BPAG1) is a member of the plakin family with cytoskeletal linker properties. Mutations in BPAG1 cause sensory neuron degeneration and skin fragility in mice...
  56. ncbi A major role for neutrophils in experimental bullous pemphigoid
    Z Liu
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Clin Invest 100:1256-63. 1997
    b>Bullous pemphigoid (BP) is an inflammatory subepidermal blistering disease associated with an IgG autoimmune response to the hemidesmosomal protein, BP180...
  57. ncbi Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid
    Z Liu
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 43226, USA
    J Exp Med 186:777-83. 1997
    ..Such an hypothesis would predict that beta2m-deficient mice would also be resistant to experimental bullous pemphigoid, a disease with a pathogenesis thought to be much simpler than SLE, being the result of antibody directed ..
  58. ncbi Dapsone as first line therapy for bullous pemphigoid
    V A Venning
    Department of Dermatology, Slade Hospital, Oxford, U K
    Br J Dermatol 120:83-92. 1989
    In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient)...
  59. ncbi The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit
    L Borradori
    Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam
    J Cell Biol 136:1333-47. 1997
    b>Bullous pemphigoid antigen 180 (BP180) is a component of hemidesmosomes, i.e., cell-substrate adhesion complexes...
  60. ncbi A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex
    D F Mutasim
    J Invest Dermatol 84:47-53. 1985
    b>Bullous pemphigoid (BP) antibodies are known to react with an antigen of the basement membrane zone (BMZ) of squamous epithelia and produce, by the indirect immunofluorescence technique, linear fluorescence at the BMZ...
  61. ncbi Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia
    M Wakugawa
    Department of Dermatology, Faculty of Medicine, University of Tokyo 7 3 1 Hongo, Bunkyo ku, Tokyo 113 8655, Japan
    Br J Dermatol 143:112-6. 2000
    b>Bullous pemphigoid (BP) often provokes blood and tissue eosinophilia, which suggests that some chemoattractants modulate the eosinophil infiltration in BP...
  62. ncbi A critical role for neutrophil elastase in experimental bullous pemphigoid
    Z Liu
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Clin Invest 105:113-23. 2000
    b>Bullous pemphigoid (BP) is an autoimmune skin disease characterized by subepidermal blisters and autoantibodies against 2 hemidesmosome-associated proteins, BP180 and BP230...
  63. ncbi Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins
    T Tanaka
    Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
    J Biol Chem 266:12555-9. 1991
    b>Bullous pemphigoid is a subepidermal blistering disease in which patients have autoantibodies against the plaque of the hemidesmosome...
  64. ncbi Increased levels of immunoreactive leukotriene B4 in blister fluids of bullous pemphigoid patients and effects of a selective 5-lipoxygenase inhibitor on experimental skin lesions
    S Kawana
    Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan
    Acta Derm Venereol 70:281-5. 1990
    The immunoreactive leukotriene B4 (i-LTB4) and i-LTC4 content in the blister fluids of patients with bullous pemphigoid (BP) was determined by radioimmunoassay...
  65. ncbi Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity
    Marco Carrozzo
    Department of Biomedical Sciences and Oncology, Oral Medicine Section, School of Medicine and Dentistry, University of Turin, Turin, Italy
    J Periodontol 75:1302-8. 2004
    ..It has been suggested that MMP exclusively involving the oral cavity could be a distinct subset, but the immunological status of patients with predominantly oral lesions has received little attention...
  66. ncbi Diagnostic value of an enzyme-linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders
    S C Hofmann
    Br J Dermatol 149:910-2. 2003
  67. ncbi Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype
    Brandie J Metz
    Department of Dermatology, Baylor College of Medicine, One Baylor Plaza FB800, Houston, TX 77030, USA
    Int J Dermatol 43:443-6. 2004
    ..woman with clinical features of LAD and with circulating IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180)...
  68. ncbi Pemphigoid nodularis: two case studies and analysis of autoantibodies before and after the development of generalized blistering
    Hirotsugu Tashiro
    Department of Dermatology, Nippon Medical School, Bunkyo-ku, Tokyo 113-8603, Japan
    J Nippon Med Sch 72:60-5. 2005
    ..Western immunoblotting of EDTA-separated epidermal extracts revealed that the 230-kD bullous pemphigoid (BP) antigen was recognized by circulating autoantibodies in the patient sera, but the 180-kD BP antigen was ..
  69. ncbi Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients
    F Mariotti
    Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Via Monti di Creta 104, 00167 Rome, Italy
    Br J Dermatol 151:1004-10. 2004
    BACKGROUND: The NC16A immunodominant region of the bullous pemphigoid (BP) antigen BP180 has been used to develop several enzyme-linked immunosorbent assays (ELISAs) as diagnostic tools for BP autoantibody detection...
  70. ncbi Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera
    P Joly
    Clinique Dermatologique et INSERM U519, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides, IFR23, Faculté Mixte de Médecine et de Pharmacie, Hopital Charles Nicolle, Rouen, France
    Dermatology 208:16-20. 2004
    We previously proposed a set of 4 clinical criteria for the diagnosis of bullous pemphigoid (BP) that consisted of age greater than 70 years, absence of atrophic scars, absence of mucosal involvement and absence of predominant bullous ..
  71. ncbi Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid
    N Sami
    Center for Blistering Diseases, Department of Medicine, New England Baptist Hospital, Boston, Massachusetts, USA
    J Eur Acad Dermatol Venereol 17:641-5. 2003
    BACKGROUND: Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease, which is characterized by blisters on the skin...
  72. ncbi A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading
    Janet A Fairley
    Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226, USA
    J Am Acad Dermatol 51:118-22. 2004
    b>Bullous pemphigoid (BP) and epidermolysis bullosa acquisita are distinct autoimmune blistering disorders...
  73. ncbi Modeling of main characteristics of bullous pemphigoid antigen-2 (BPAG2) peptide structure in serological recognition by autoantibodies
    Jozsef Pal
    Department of Immunology and Biotechnology, University of Pecs, Faculty of Medicine, Pecs, Hungary
    Pathol Oncol Res 10:52-6. 2004
    The serum level of autoantibodies against autoantigens of the bullous pemphigoid peptides 1 and 2 (BPAG1 and BPAG2) is a relevant diagnostic marker...
  74. ncbi Development of an ELISA for the detection of autoantibodies to BP230
    Arno Kromminga
    Institute for Immunology, Clinical Pathology, and Molecular Medicine (IPM, Hamburg, Germany
    Clin Immunol 111:146-52. 2004
    b>Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies against the transmembrane hemidesmosomal protein BP180/collagen type XVII and the intracellular plaque protein BP230...
  75. ncbi Humanization of autoantigen
    Wataru Nishie
    Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo 060 8638, Japan
    Nat Med 13:378-83. 2007
    ..Here we show that human autoimmune disease can be reproduced using genetically engineered model mice. Bullous pemphigoid (BP) is the most common serious autoimmune blistering skin disease, with a considerable body of indirect ..
  76. ncbi BP230- and BP180-specific auto-antibodies in bullous pemphigoid
    Sybille Thoma-Uszynski
    Department of Dermatology, Friedrich Alexander University, Erlangen Nurnberg, Germany
    J Invest Dermatol 122:1413-22. 2004
    b>Bullous pemphigoid is a subepidermal blistering disease associated with auto-antibodies (auto-ab) to BP180 and BP230...
  77. ncbi Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting
    Nemesha Desai
    Department of Dermatology, The Oxford Radcliffe Hospital, Oxford, UK
    Australas J Dermatol 49:137-41. 2008
    Autoantibodies to basement membrane proteins BP180 and BP230 are characteristic of bullous pemphigoid and other subepidermal immunobullous disorders...
  78. ncbi [Autoimmune blistering diseases]
    Masayuki Amagai
    Department of Dermatology, Keio University School of Medicine
    Nippon Rinsho 63:540-6. 2005
  79. ncbi Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies
    Cassian Sitaru
    Department of Dermatology, University of Lubeck, Ratzeburger Allee 160, Lubeck, Germany
    Exp Dermatol 16:770-7. 2007
    b>Bullous pemphigoid (BP) and pemphigoid gestationis (PG) are acquired autoimmune subepidermal blistering diseases characterized by autoantibodies against the hemidesmosomal proteins BP180/type XVII collagen and BP230...
  80. ncbi Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid
    M Kakurai
    Clin Exp Dermatol 32:759-61. 2007
  81. ncbi Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid
    Lisa Leighty
    Department of Dermatology, University of North Carolina School of Medicine, 3100 Thurston Bowles, Chapel Hill, NC 27599, USA
    Arch Dermatol Res 299:417-22. 2007
    b>Bullous pemphigoid (BP) is a subepidermal skin blistering disease characterized immunohistologically by dermal-epidermal junction (DEJ) separation, an inflammatory cell infiltrate in the upper dermis, and autoantibodies targeted toward ..
  82. ncbi IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice
    John J Zone
    Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    J Invest Dermatol 127:1167-74. 2007
    b>Bullous pemphigoid (BP) is characterized by the deposition of IgG in the basement membrane zone, infiltration of eosinophils, and blister formation...
  83. ncbi Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease
    Amrei Dilling
    Department of Dermatology, University of Lubeck, Germany
    J Dermatol 34:1-8. 2007
    ..to be immunologically and biochemically distinct from all major autoantigens of the DEJ, including bullous pemphigoid antigens 180 and 230, laminin 1, 5 and 6, alpha6beta4 integrin, and type VII collagen...
  84. ncbi [Diagnostic methods in autoimmune subepidermal bullous diseases]
    Minia Campos Dominguez
    Unidad de Enfermedades Ampollosas, Hospital General Universitario Gregorio Maranon, Madrid, Espana
    Actas Dermosifiliogr 97:485-502. 2006
    ..We explain the methodology and diagnostic keys of the techniques most widely applied in our milieu...
  85. ncbi Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values
    Dimitrios Andreadis
    Department of Oral Medicine and Maxillofacial Pathology, School of Dentistry, Aristotle University of Thessaloniki, Greece
    Eur J Oral Sci 114:374-80. 2006
    ..By contrast, the titres of autoantibodies against BP180 in the serum and saliva of bullous pemphigoid patients were not statistically related, and further study of the usefulness of the BP180 ELISA for saliva ..
  86. ncbi Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid
    Nobuko Ishiura
    Department of Dermatology, Graduate School of Medicine, University of Tokyo, Bunkyo, Tokyo, Japan
    J Dermatol Sci 49:153-61. 2008
    b>Bullous pemphigoid (BP) is a subepidermal blistering disease characterized by autoantibodies against the hemidesmosomal proteins, BP180 and BP230...
  87. ncbi Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris
    N Asashima
    Department of Dermatology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan
    Br J Dermatol 155:330-6. 2006
    ..examine whether BAFF levels are elevated in the autoimmune blistering diseases pemphigus vulgaris (PV) and bullous pemphigoid (BP). METHODS: We examined sera obtained from 21 patients with PV, 39 patients with BP and 22 healthy donors...
  88. ncbi Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid
    C Chiaverini
    Department of Dermatology, Hospital Necker Enfants Malades, Paris, and Clinical and Experimental Immunology Laboratory, University of Medicine, Rouen, France
    Br J Dermatol 154:839-43. 2006
    It is not clear whether bullous pemphigoid (BP) of infancy is linked to maternal transmission of pathogenic autoantibodies...
  89. ncbi Efficacy of interferon-gamma in patients with refractory bullous pemphigoid
    Takekuni Nakama
    Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    J Dermatol 34:737-45. 2007
    b>Bullous pemphigoid (BP) usually responds well to conventional therapies, although some severe cases show less response to various therapies or develop side-effects due to long-term drug administration using high doses...
  90. ncbi [A severe course of bullous pemphigoid in a young man]
    S Eigelshoven
    ,
    Hautarzt 57:320-2. 2006
  91. ncbi Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
    Ning Li
    Department of Dermatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA
    J Clin Invest 115:3440-50. 2005
    ..In this study, we used IgG passive transfer murine models of bullous pemphigoid (BP), pemphigus foliaceus (PF), and pemphigus vulgaris (PV) to test the hypothesis that the effect of IVIG ..
  92. ncbi Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China
    Suying Feng
    Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China
    Int J Dermatol 47:24-8. 2008
    Autoantibodies of bullous pemphigoid (BP) patients react with two components of the hemidesmosome of stratified epithelia: the BP antigen 230 (BP230) and the BP antigen 180 (BP180)...
  93. ncbi Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid
    Suying Feng
    Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China
    Int J Dermatol 47:225-8. 2008
    The 180-kDa transmembrane hemidesmosomal protein (BPAG2) has been identified as an important autoantigen in bullous pemphigoid (BP)...
  94. ncbi Bullous pemphigoid: physiopathology, clinical features and management
    Giovanni Di Zenzo
    Molecular and Cell Biology Laboratory, Istituto Dermopatico dell Immacolata, IDI IRCCS, Via Monti di Creta 104, 00167 Rome, Italy
    Adv Dermatol 23:257-88. 2007
    ....
  95. ncbi Th2 cell fluctuation in association with reciprocal occurrence of bullous pemphigoid and psoriasis vulgaris
    K Sugita
    J Eur Acad Dermatol Venereol 21:569-70. 2007
  96. ncbi Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid
    Otobia G Dimson
    Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Invest Dermatol 120:784-8. 2003
    b>Bullous pemphigoid (BP) is an autoimmune skin disease characterized by autoantibodies against the hemidesmosomal protein BP180. In addition to IgG autoantibodies, IgE class autoantibodies have been reported in BP patients...
  97. ncbi Are anti-BP180 IgG1 or IgG4 autoantibodies pathogenic?
    Zhi Liu
    Departments of Dermatology, Microbiology and Immunology, University of North Carolina, Chapel Hill, USA
    J Invest Dermatol 119:989-90. 2002
  98. ncbi New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria
    M Blank
    Department of Medicine B and Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Rheumatol 24:S20-5. 2006
    ..In a subsets of patients with chronic urticaria mast cell degranulation is induced by autoantibodies directed against the a-subunit of the high-affinity IgE receptor, and/or the IgE...
  99. ncbi A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180
    Enno Schmidt
    Department of Biotechnology, Biocenter, , , Germany
    J Autoimmun 18:299-309. 2002
    b>Bullous pemphigoid antigen 180 (BP180) is the target of autoantibodies in various subepidermal blistering diseases. The most common one is bullous pemphigoid (BP)...
  100. ncbi [Simultaneous onset of pemphigoid and factor VIII antibody hemophilia]
    C Maczek
    ,
    Hautarzt 53:412-5. 2002
    ..Eventually, reduction of circulating autoantibodies by a combination of plasmapheresis and subsequent immunosuppressive therapy led to a stable remission of both autoimmune bullous skin disorder and acquired haemophilia...
  101. ncbi Bullous pemphigoid in Liguria: a 2-year survey
    E Cozzani
    Clinica Dermatologica, , Italy
    J Eur Acad Dermatol Venereol 15:317-9. 2001
    BACKGROUND: The epidemiology of bullous pemphigoid (BP) is not clear because of the heterogeneity of the disease, and its possible association with internal malignancies has been under debate for many years...

Research Grants71

  1. Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
    Tanya N Mayadas; Fiscal Year: 2010
    ..and 5) demonstrate a critical role for Mac-1 on neutrophils in two additional complement dependent models, bullous pemphigoid and thrombotic glomerulonephritis. The current application builds on these discoveries...
  2. PEMPHIGUS AND PEMPHIGOID
    Luis Diaz; Fiscal Year: 2005
    ..vulgaris (PV), non-endemic pemphigus foliaceus (PF), endemic PF [also known as Fogo Selvagem (FS)] and Bullous Pemphigoid (BP) that are summarized as follows: a) we have developed animals models of PV , PF, and FS by passive ..
  3. Mechanism of neurodegeneration in dystonia musculorum
    RONALD LIEM; Fiscal Year: 2007
    ..The gene that is mutated in dt mice is called dystonin, and is also known as bullous pemphigoid antigen 1 (BPAG1). BPAG1 is a member of the plakin family of cytoskeletal linker proteins...
  4. Complement Anaphylatoxin Receptors in Inflammation
    RICK WETSEL; Fiscal Year: 2005
    ..deficiency in the skin using established models of infectious dermatitis, immune-complex injury, and bullous pemphigoid, and 4) to determine the effect of C3a receptor deficiency in the peritoneum using established models of ..
  5. INTESTINAL TRANSCYTOSIS OF IGG IN ADULT LIFE
    Richard Blumberg; Fiscal Year: 2007
    ..FcRn has been shown to regulate the development of immune-mediated diseases such as rheumatoid arthritis and bullous pemphigoid. This raises the possibility that blockade of FcRn function may be of therapeutic utility in colitis if our ..
  6. INTESTINAL TRANSCYTOSIS OF IGG IN ADULT LIFE
    Richard S Blumberg; Fiscal Year: 2010
    ..FcRn has been shown to regulate the development of immune-mediated diseases such as rheumatoid arthritis and bullous pemphigoid. This raises the possibility that blockade of FcRn function may be of therapeutic utility in colitis if our ..
  7. INTESTINAL TRANSCYTOSIS OF IGG IN ADULT LIFE
    Richard Blumberg; Fiscal Year: 2009
    ..FcRn has been shown to regulate the development of immune-mediated diseases such as rheumatoid arthritis and bullous pemphigoid. This raises the possibility that blockade of FcRn function may be of therapeutic utility in colitis if our ..
  8. CYTOTOXIC MECHANISMS IN CUTANEOUS DISEASE
    David Norris; Fiscal Year: 1990
    ..Finally, we will begin pilot projects to study antibody dependent cytotoxicity in other skin diseases such as pemphigus vulgaris, bullous pemphigoid, alopecia areata, and vitiligo.
  9. EPITHELIALIZATION OF TISSUE ENGINEERED CORNEAS
    JEAN JACOB; Fiscal Year: 2003
    ..and F-actin, jet impingement to determine cellular adhesion, and immunohistochemistry for laminin, bullous pemphigoid antigen, and collagen VII...
  10. HEMIDESMOSOMES IN BULLOUS PEMPHIGOID
    GEORGE GIUDICE; Fiscal Year: 2007
    ..an autoimmune response directed against the BP180 protein is a key initiatory step in the pathogenesis of bullous pemphigoid and several other acquired blistering diseases...
  11. HEMIDESMOSOMES IN BULLOUS PEMPHIGOID
    GEORGE GIUDICE; Fiscal Year: 2007
    ..an autoimmune response directed against the BP180 protein is a key initiatory step in the pathogenesis of bullous pemphigoid and several other acquired blistering diseases...
  12. HEMIDESMOSOMES IN BULLOUS PEMPHIGOID
    GEORGE GIUDICE; Fiscal Year: 2002
    b>Bullous pemphigoid (BP) is a subepidermal blistering disease characterized by the production of autoantibodies that react with components of the hemidesmosome, an adhesion-related organelle of basal epidermal keratinocytes...
  13. A Transgenic Animal Model for Pemphigoid
    KIM YANCEY; Fiscal Year: 2007
    ..b>Bullous pemphigoid antigen 2 (BPAG2), a type II transmembrane protein in hemidesmosomes, is a major autoantigen bound by such ..
  14. A Transgenic Animal Model for Pemphigoid
    KIM YANCEY; Fiscal Year: 2006
    ..b>Bullous pemphigoid antigen 2 (BPAG2), a type II transmembrane protein in hemidesmosomes, is a major autoantigen bound by such ..